147 related articles for article (PubMed ID: 21900384)
1. Proximal promoter of the cytochrome P450 oxidoreductase gene: identification of microdeletions involving the untranslated exon 1 and critical function of the SP1 binding sites.
Soneda S; Yazawa T; Fukami M; Adachi M; Mizota M; Fujieda K; Miyamoto K; Ogata T
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1881-7. PubMed ID: 21900384
[TBL] [Abstract][Full Text] [Related]
2. P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.
Miller WL
Sci Signal; 2012 Oct; 5(247):pt11. PubMed ID: 23092891
[TBL] [Abstract][Full Text] [Related]
3. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency.
Scott RR; Gomes LG; Huang N; Van Vliet G; Miller WL
J Clin Endocrinol Metab; 2007 Jun; 92(6):2318-22. PubMed ID: 17389698
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the TATA-less NADPH cytochrome P-450 oxidoreductase gene.
O'Leary KA; McQuiddy P; Kasper CB
Arch Biochem Biophys; 1996 Jun; 330(2):271-80. PubMed ID: 8660656
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for cell-specific regulation of the NADPH-cytochrome P450 oxidoreductase gene.
O'Leary KA; Kasper CB
Arch Biochem Biophys; 2000 Jul; 379(1):97-108. PubMed ID: 10864447
[TBL] [Abstract][Full Text] [Related]
6. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms.
Tee MK; Huang N; Damm I; Miller WL
Mol Endocrinol; 2011 May; 25(5):715-31. PubMed ID: 21393444
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients.
Fukami M; Nishimura G; Homma K; Nagai T; Hanaki K; Uematsu A; Ishii T; Numakura C; Sawada H; Nakacho M; Kowase T; Motomura K; Haruna H; Nakamura M; Ohishi A; Adachi M; Tajima T; Hasegawa Y; Hasegawa T; Horikawa R; Fujieda K; Ogata T
J Clin Endocrinol Metab; 2009 May; 94(5):1723-31. PubMed ID: 19258400
[TBL] [Abstract][Full Text] [Related]
9. [Antley-Bixler syndrome or POR deficiency?].
Tomková M; Marohnic CC; Baxová A; Martásek P
Cas Lek Cesk; 2008; 147(5):261-5. PubMed ID: 18630181
[TBL] [Abstract][Full Text] [Related]
10. P450 oxidoreductase deficiency: a new disorder of steroidogenesis.
Miller WL; Huang N; Pandey AV; Flück CE; Agrawal V
Ann N Y Acad Sci; 2005 Dec; 1061():100-8. PubMed ID: 16467261
[TBL] [Abstract][Full Text] [Related]
11. The gonadotropin-regulated long-chain acyl CoA synthetase gene: a novel downstream Sp1/Sp3 binding element critical for transcriptional promoter activity.
Sheng Y; Li J; Dufau ML; Tsai-Morris CH
Gene; 2005 Oct; 360(1):20-6. PubMed ID: 16125341
[TBL] [Abstract][Full Text] [Related]
12. Conditional deletion of cytochrome p450 reductase in osteoprogenitor cells affects long bone and skull development in mice recapitulating antley-bixler syndrome: role of a redox enzyme in development.
Panda SP; Guntur AR; Polusani SR; Fajardo RJ; Gakunga PT; Roman LJ; Masters BS
PLoS One; 2013; 8(9):e75638. PubMed ID: 24086598
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes.
Zhao Y; Mendelson CR; Simpson ER
Mol Endocrinol; 1995 Mar; 9(3):340-9. PubMed ID: 7776980
[TBL] [Abstract][Full Text] [Related]
14. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
[TBL] [Abstract][Full Text] [Related]
15. Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency.
Koika V; Armeni AK; Georgopoulos NA
Hormones (Athens); 2016 Apr; 15(2):277-282. PubMed ID: 27376429
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects.
Fukami M; Ogata T
Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558
[TBL] [Abstract][Full Text] [Related]
17. Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency.
Lee Y; Choi JH; Oh A; Kim GH; Park SH; Moon JE; Ko CW; Cheon CK; Yoo HW
Ann Pediatr Endocrinol Metab; 2020 Jun; 25(2):97-103. PubMed ID: 32615689
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical consequences of p450 oxidoreductase deficiency.
Flück CE; Pandey AV
Endocr Dev; 2011; 20():63-79. PubMed ID: 21164260
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic analysis of cytochrome P450 oxidoreductase (POR) deficiency in a female and the analysis of a novel POR intron mutation causing alternative mRNA splicing : Overall analysis of a female with POR deficiency.
Zhang T; Li Z; Ren X; Huang B; Zhu G; Yang W; Jin L
J Assist Reprod Genet; 2020 Oct; 37(10):2503-2511. PubMed ID: 32725309
[TBL] [Abstract][Full Text] [Related]
20. A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity.
Wang X; Talamantez JL; Adamo ML
Endocrinology; 1998 Mar; 139(3):1054-66. PubMed ID: 9492038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
